Whalen Matthew Pratt
Reporting Owner SEC Filing List
CIK: 0002033867
| Form | Filer | Subject Company | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Telomir Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 05/22/2026 | |
| 4 | Statement of changes in beneficial owner... | Whalen Matthew Pratt | 05/22/2026 | ||
| 4 | Statement of changes in beneficial owner... | Whalen Matthew Pratt | M2 Compliance Llc /fa | 12/10/2024 | |
| 4 | Statement of changes in beneficial owner... | Mira Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 12/10/2024 | |
| 3 | Initial statement of beneficial ownershi... | Mira Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 11/26/2024 | |
| 3 | Initial statement of beneficial ownershi... | Whalen Matthew Pratt | M2 Compliance Llc /fa | 11/26/2024 | |
| 3 | Initial statement of beneficial ownershi... | Telomir Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 08/15/2024 | |
| 3 | Initial statement of beneficial ownershi... | Whalen Matthew Pratt | M2 Compliance Llc /fa | 08/15/2024 |
Whalen Matthew Pratt 's Ownership Transactions
| Issuer | Filing Date | Transaction Date | Transaction Type | Shares | Price | Total Amt | Shares Owned |
|---|
